Cubist Systematic Strategies, LLC Icosavax, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $17.3 Billion
  • Q1 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$5.62 - $11.51 $66,613 - $136,428
-11,853 Reduced 15.56%
64,308 $372,000
Q4 2022

Feb 14, 2023
BUY
$2.32 - $10.97 $119,271 - $563,967
51,410 Added 207.71%
76,161 $604,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $9.21 $76,480 - $227,956
24,751 New
24,751 $78,000
Q3 2022

Nov 14, 2022
BUY
$3.09 - $9.21 $76,480 - $227,956
24,751 New
24,751 $78,000
Q2 2022

Aug 15, 2022
SELL
$5.7 - $10.33 $285,758 - $517,873
-50,133 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.41 - $22.5 $221,086 - $1.13 Million
50,133 New
50,133 $353,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email